Coloplast A/S
COLO-B
Rang in Aktien
#1334
Coloplast A/S engages in the development and sale of intimate healthcare... Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Aktienkurs
$75.08
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$16.92B
Veränderung (1 Tag)
1.26%
Veränderung (1 Jahr)
-12.93%
Land
DK
Handel Coloplast A/S (COLO-B)
Kategorie
Healthcare
Marktkapitalisierung von Coloplast A/S(COLO-B)
Marktkapitalisierung: $16.92B
Mit Stand October 2026 hat Coloplast A/S eine Marktkapitalisierung von $16.92B. Das macht Coloplast A/S laut unseren Daten zum 1334th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Coloplast A/S von 2000 bis 2026
COLO-B im Vergleich zu den Top 5 der beliebtesten stocks
